相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Absolute Difference of Hepatobiliary Transporter Multidrug Resistance-Associated Protein (MRP2/Mrp2) in Liver Tissues and Isolated Hepatocytes from Rat, Dog, Monkey, and Human
Na Li et al.
DRUG METABOLISM AND DISPOSITION (2009)
A Framework for Assessing Inter-individual Variability in Pharmacokinetics Using Virtual Human Populations and Integrating General Knowledge of Physical Chemistry, Biology, Anatomy, Physiology and Genetics: A Tale of 'Bottom-Up' vs 'Top-Down' Recognition of Covariates
Masoud Jamei et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Presentation of a modified dispersion model (MDM) for hepatic drug extraction and a new methodology for the prediction of the rate-limiting step in hepatic metabolic clearance
U. Fagerholm
XENOBIOTICA (2009)
Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes
Stuart W. Paine et al.
DRUG METABOLISM AND DISPOSITION (2008)
The Albumin Effect and drug glucuronidation: Bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities
Andrew Rowland et al.
DRUG METABOLISM AND DISPOSITION (2008)
The albumin effect and in vitro-in vivo extrapolation: Sequestration of long-chain unsaturated fatty acids enhances phenytoin hydroxylation by human liver microsomal and recombinant cytochrome P4502C9
Andrew Rowland et al.
DRUG METABOLISM AND DISPOSITION (2008)
Design, Data Analysis, and Simulation of in Vitro Drug Transport Kinetic Experiments Using a Mechanistic in Vitro Model
Agnes Poirier et al.
DRUG METABOLISM AND DISPOSITION (2008)
In vitro biliary clearance of angiotensin II receptor blockers and 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors in sandwich-cultured rat hepatocytes: Comparison with in vivo biliary clearance
Koji Abe et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Applications of physiologically based absorption models in drug discovery and development
Neil Parrott et al.
MOLECULAR PHARMACEUTICS (2008)
Reliability of human cryopreserved hepatocytes and liver microsomes as in vitro systems to predict metabolic clearance
R. Stringer et al.
XENOBIOTICA (2008)
Prediction of human pharmacokinetics - renal metabolic and excretion clearance
Urban Fagerholm
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
Prediction of intestinal first-pass drug metabolism
Jiansong Yang et al.
CURRENT DRUG METABOLISM (2007)
In vitro methods to study intestinal drug metabolism
Esther G. van de Kerkhof et al.
CURRENT DRUG METABOLISM (2007)
On the anticipation of the human dose in first-in-man trials from preclinical and prior clinical information in early drug development
P. J. Lowe et al.
XENOBIOTICA (2007)
Challenges and opportunities with modelling and simulation in drug discovery and drug development
T. Lave et al.
XENOBIOTICA (2007)
Prediction of human pharmacokinetics - gut-wall metabolism
Urban Fagerholm
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
Prediction of human pharmacokinetics using physiologically based modeling: A retrospective analysis of 26 clinically tested drugs
Stefan S. De Buck et al.
DRUG METABOLISM AND DISPOSITION (2007)
An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture
Philip J. Lee et al.
BIOTECHNOLOGY AND BIOENGINEERING (2007)
Mechanistic approaches to volume of distribution predictions: Understanding the processes
Trudy Rodgers et al.
PHARMACEUTICAL RESEARCH (2007)
Binding of inhibitory fatty acids is responsible for the enhancement of UDP-glucuronosyltransferase 2B7 activity by albumin: Implications for in vitro-in vivo extrapolation
Andrew Rowland et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
In vitro-in vivo correlation of hepatobiliary drug clearance in humans
G. Ghibellini et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Simulation and prediction of in vivo drug metabolism in human populations from in vitro data
Amin Rostami-Hodjegan et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data:: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver
Zoe E. Barter et al.
CURRENT DRUG METABOLISM (2007)
Intestinal and hepatic metabolic activity of five cytochrome p450 enzymes: Impact on prediction of first-pass metabolism
Aleksandra Galetin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Integrating in vitro ADMET data through generic physiologically based pharmacokinetic models
David E. Leahy
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Prediction of metabolic drug clearance in humans:: In vitro-in vivo extrapolation vs allometric scaling
M. R. Shiran et al.
XENOBIOTICA (2006)
In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: Pitfalls and promises
JO Miners et al.
BIOCHEMICAL PHARMACOLOGY (2006)
The human intestinal cytochrome P450 pie
MF Paine et al.
DRUG METABOLISM AND DISPOSITION (2006)
A novel strategy for physiologically based predictions of human pharmacokinetics
HM Jones et al.
CLINICAL PHARMACOKINETICS (2006)
Prediction of in vivo drug clearance from in vitro data. I: Impact of inter-individual variability
E. M. Howgate et al.
XENOBIOTICA (2006)
Application of a generic physiologically based pharmacokinetic model to the estimation of xenobiotic levels in human plasma
FA Brightman et al.
DRUG METABOLISM AND DISPOSITION (2006)
A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters
H Tahara et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes
RJ Riley et al.
DRUG METABOLISM AND DISPOSITION (2005)
Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches
K Ito et al.
PHARMACEUTICAL RESEARCH (2005)
Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors
NJ Proctor et al.
XENOBIOTICA (2004)
The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants
O Bernard et al.
DRUG METABOLISM AND DISPOSITION (2004)
The chimpanzee (Pan troglodytes) as a pharmacokinetic model for selection of drug candidates:: Model characterization and application
H Wong et al.
DRUG METABOLISM AND DISPOSITION (2004)
Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7
P Tsoutsikos et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes
N Blanchard et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Prediction of in vivo hepatic clearance from in vitro data using cryopreserved human hepatocytes
K Bachmann et al.
XENOBIOTICA (2003)
In vitro-in vivo correlations for drugs eliminated by glucuronidation:: Investigations with the model substrate zidovudine
S Boase et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: An application of serum incubation method
Y Shibata et al.
DRUG METABOLISM AND DISPOSITION (2002)
Interspecies scaling of biliary excreted drugs
I Mahmood et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance
MG Soars et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes
K Bowalgaha et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique
O von Richter et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions
KA Bachmann et al.
CURRENT DRUG METABOLISM (2001)
Interindividual variability in inhibition and induction of cytochrome P450 enzymes
JH Lin et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Prediction of hepatic metabolic clearance - Comparison and assessment of prediction models
J Zuegge et al.
CLINICAL PHARMACOKINETICS (2001)
分享论文
